MoneyWorks4Me

The March 2023 quarter revenue stood at Rs. 1124.60 millions, up 9.67% as compared to Rs. 1025.42 millions during the corresponding quarter last year.A humble growth in net profit of 13.96% reported in the quarter ended March 2023 to Rs. 125.63  millions from Rs. 110.24 millions.The company reported a good operating profit of 205.43 millions compared to 193.26 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1124.60 1025.42 9.67 5103.09 4720.79 8.10 5103.09 4720.79 8.10
Other Income 39.46 18.91 108.67 224.84 99.98 124.88 224.84 99.98 124.88
PBIDT 205.43 193.26 6.30 1116.50 1054.68 5.86 1116.50 1054.68 5.86
Interest 11.48 5.66 102.83 20.29 14.51 39.83 20.29 14.51 39.83
PBDT 193.95 187.60 3.38 1096.21 1040.17 5.39 1096.21 1040.17 5.39
Depreciation 24.13 19.98 20.77 91.66 80.88 13.33 91.66 80.88 13.33
PBT 169.82 167.62 1.31 1004.55 959.29 4.72 1004.55 959.29 4.72
TAX 44.19 57.38 -22.99 275.56 265.74 3.70 275.56 265.74 3.70
Deferred Tax 10.11 5.64 79.26 15.86 7.20 120.28 15.86 7.20 120.28
PAT 125.63 110.24 13.96 728.99 693.55 5.11 728.99 693.55 5.11
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 18.27 18.85 -3.08 21.88 22.34 -2.07 21.88 22.34 -2.07
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..